Your current location: 99jili >>is jili777 legit or not >>main body

swerte99 casino

https://livingheritagejourneys.eu/cpresources/twentytwentyfive/ swerte99 casino register 2025-02-04

swerte99 casino

swerte99 casino Farmers need a reality check on Trump’s tariff war

Intuitive Surgical Inc. stock outperforms competitors despite losses on the dayThe state government will launch a parliamentary inquiry into regional housing supply as it steps up its effort to tackle the crisis in country Victoria. or signup to continue reading Leader of the House and Macedon MP Mary-Anne Thomas will give notice of a motion to establish the inquiry on November 27. Premier Jacinta Allan to tackle the housing crisis in October, but no new policies to specifically tackle the issue in the regions. A government spokesperson said the new inquiry would find out what kind of housing country Victorians needed, and how it could best be delivered. Ms Thomas's motion said the inquiry would "get regional MPs out into the communities talking about housing for the next 12 months". It will report back by December 15 2025. An ACM investigation revealed the government's Big Housing Build had already allocated more than its promised $1.25 billion investment to regional Victoria. But it also showed the program was to increase the state's social housing stock by 10 per cent. For every two houses built under the Big Build, the government was having to demolish or sell one, and in regional Victoria the increase in housing was lagging well behind the number of new houses. The government has also started rolling out a $1 billion Regional Housing Fund. under the program, but the 1300 figure now comprises at least 500 existing Homes Victoria dwellings that were previously uninhabitable. A government spokesperson said a key part of the inquiry would be assessing the delivery of the Big Build and Regional Housing Fund to ensure they were providing the promised benefits. It will also investigate the cost of building houses under the programs. The cost per house under the Big Build in regional Victoria ranged from $350,877 in Wangaratta, to $439,024 in Warrnambool. But the 1300 new and "upgraded" houses under the Regional Housing Fund will cost about $770,000 each. The inquiry will be done by the Legislative Assembly's Environment and Planning Committee, chaired by Wendouree MP Juliana Addison. Every regional MP will be expected to build a picture of the housing need in their district, including the ideal mix of social and affordable dwellings. But the inquiry will also explore efficient and innovative building methods, including whether modular and prefabricated housing could improve the amenity of an area quickly and cost-effectively. Another focus will be the need for smaller dwellings compared to three and four-bedroom homes, and whether apartments could efficiently fill the housing need in larger cities. The government's suite of housing announcements in October included cuts to red tape and stamp duty, as well as a plan to force developers to contribute their fair share to local infrastructure. Developers face . In south-west Victoria, councils like Warrnambool City and Moyne Shire have been forced to create their own key worker housing because planning challenges and a lack of developer interest have made new developments rare. In Ballarat, some growth areas have sat in activation limbo while other potential housing areas remain undeveloped because crucial infrastructure is lagging five or 10 years behind housing demand. A government spokesperson said the inquiry would seek input from developers to find out what changes would help them build more housing more quickly in regional areas. The government has also opened a second round of its Regional Worker Accommodation Fund, which offers grants from $150,000 to $5 million to businesses, councils, or community groups to deliver key worker housing. The first round stimulated $250 million in public-private investment for "shovel-ready" regional housing projects. Ms Allan - whose hometown of Bendigo faces one of the biggest housing shortfalls in the state - said the government wanted to give "more families the opportunities they deserve to live in the communities they love". Correspondent covering key issues across regional Victoria, based in Melbourne. Correspondent covering key issues across regional Victoria, based in Melbourne. DAILY Today's top stories curated by our news team. WEEKDAYS Grab a quick bite of today's latest news from around the region and the nation. WEEKLY The latest news, results & expert analysis. WEEKDAYS Catch up on the news of the day and unwind with great reading for your evening. WEEKLY Get the editor's insights: what's happening & why it matters. WEEKLY Love footy? We've got all the action covered. WEEKLY Every Saturday and Tuesday, explore destinations deals, tips & travel writing to transport you around the globe. WEEKLY Going out or staying in? Find out what's on. WEEKDAYS Sharp. Close to the ground. Digging deep. Your weekday morning newsletter on national affairs, politics and more. TWICE WEEKLY Your essential national news digest: all the big issues on Wednesday and great reading every Saturday. WEEKLY Get news, reviews and expert insights every Thursday from CarExpert, ACM's exclusive motoring partner. TWICE WEEKLY Get real, Australia! Let the ACM network's editors and journalists bring you news and views from all over. AS IT HAPPENS Be the first to know when news breaks. DAILY Your digital replica of Today's Paper. Ready to read from 5am! DAILY Test your skills with interactive crosswords, sudoku & trivia. Fresh daily! Advertisement AdvertisementCHIPOTLE MEXICAN GRILL TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 RESULTS ON FEBRUARY 4, 2025

None

Pelosi on Hunter Biden pardon: 'I support the president'

News of an analyst's price-target hike plus a new round of capital-raising were the sparks that ignited Janux Therapeutics ( JANX 11.65% ) stock on Wednesday. The clinical-stage biotech's share price ended the day nearly 12% higher, and this was on a very good day for the exchange with the S&P 500 rising by 0.6%. Price-target raised, new shares floated Well before market open, Scotiabank pundit George Farmer aggressively raised his price target on Janux, cranking it nearly 50% higher to $62 per share. That doesn't necessarily make him a bull, though, as he maintained his recommendation of sector perform (hold, in other words). According to reports, Farmer wrote that the biotech company's current phase 1 trial of its JANX007 prostate cancer treatment is rather promising so far. That said, the analyst believes Janux hasn't yet honed a sharp competitive edge and isn't yet an attractive enough target for a pharmaceutical company to acquire it. What Janux has done, however, is push to extend its runway with a fresh share issue. After market hours Tuesday, the company said it had launched a $300 million secondary common stock flotation. Certain investors will have the option of purchasing pre-funded warrants instead of shares, and the issue's underwriters are expected to be granted a 30-day option to purchase an additional $45 million worth of shares collectively. A promising future? Janux said it aims to use its proceeds from the share issue "to advance clinical development of its internal product pipeline," in addition to general corporate purposes. The company focuses on cancer treatments, which continues to be a hot area for biotechs, but Farmer makes a good point that Janux hasn't distinguished itself sufficiently. However, it's a relatively young enterprise, and those recent clinical readouts are encouraging.CHIPOTLE MEXICAN GRILL TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 RESULTS ON FEBRUARY 4, 2025

None

Covid origin revealed after bombshell probe

Adani’s ‘renewable energy marvel’ trapped in US bribery indictment NEW DELHI: Betting big on the clean energy goals of Indian Prime Minister Narendra Modi, billionaire Gautam Adani found backers in France’s TotalEnergies and the Qatar Investment Authority as he set out to build the world’s biggest renewable energy project. The crown jewel of his company, Adani Green, is an energy park in western Gujarat state planned to be five times the size of Paris on completion, and producing 50 gigawatts by 2030, or roughly a tenth of India’s clean energy goals. Now the plan faces a hurdle in the form of a US indictment of Adani, his nephew and executive director Sagar Adani and managing director Vneet S Jaain, accusing them of paying bribes of $265 million to secure Indian power supply contracts, and misleading US investors during fund raises there. Since the news, stock of Adani Green has nosedived 36 per cent, losing $9.6 billion in market value.Adani Group has denied the accusations in the US indictment as baseless, and vowed to seek all legal recourse.But fund-raising could get complicated. “To the extent of raising additional capital for newer projects, any sort of regulatory issues become problematic,” said Deepika Mundra, a senior analyst at M&G Investments based in Britain. “Particularly if you want to tap international markets.” Adani Green is one of many public and private companies key to helping India achieve its goals, she added. “It is quite important that all these (Adani Green) projects go through.”The Adani Green boom is reflected in a surge of 10,000 per cent in its shares between 2018 and 2022 as power demand in India swells, spurring it to develop the energy park in Khavda in Gujarat. “For us, this renewable energy park is a symbol of our commitment to sustainability and a symbol of national pride,” Adani wrote in his annual report in June.When complete, its output would be “enough to power nations like Belgium, Chile, and Switzerland”, he added. Adani has committed investment of $100 billion in the renewables sector, seen as core to the ports-to-airports conglomerate that is worth more than $135 billion.Now the tide is turning for Adani Green, described by US prosecutors as being at the heart of ‘The Corrupt Solar Project’. After the US indictment, TotalEnergies, which holds a stake of nearly 19.8 per cent in Adani Green, was among the first to react, saying it would not invest more in the group for now. It had not been made aware of the bribery case, even though Sagar Adani was served a grand jury subpeona last year by the US Federal Bureau of Investigation, it added. The Qatar Investment Authority, with a stake of 2.7 per cent, declined comment. But standing firm for now is GQG Investors, which holds a stake of 4.2 per cent. In an internal client note seen by Reuters, it said, “We believe the fundamentals of the companies we are invested in remain sound”. Adani Green added power capacity of 37 per cent each year to reach 11.2 GW by September this year, from a mere 2 GW in the 2018-19 financial year.Its next big target is 50 GW goal by 2030, or a capacity addition of 31 per cent each year, it told investors in a presentation in November. ‘RENEWABLE ENERGY MARVEL’ Adani Green’s revenues of $574 million during the period from April to September this year were up 20 per cent on the year, boosting its cash profit 27 per cent to $313 million over that time.With large solar, wind and hybrid power developments in Gujarat and the desert state of Rajasthan, it is developing smaller pumped-storage hydro power projects in five Indian states. The facilities in Rajasthan and Gujarat were to have supplied the power contracted for in the Adani deals that US prosecutors allege to have been granted after payment of bribes.One of them is the partly developed marquee project in Khavda, just 18 miles (30 km) from the international border with Pakistan. It is described by Adani as “a renewable energy marvel in the making”. Adani is targeting a massive jump in operational capacity at the location to 30 GW by 2029, up from 2.25 GW now. Energy from the park can power 16.1 million homes each year, Adani says. Reuters was among media which toured the project site in April, when thousands of labourers worked on construction and scores of solar panels were being installed.Engineers that day talked up the potential of the project, which would sprawl across 540 sq km (210 sq miles) when complete, saying it would be visible from space. “The kind of support being provided by the central government, and I must say, the state governments also, is extraordinary,” Managing Director Vneet S Jaain said at the time.Jaain, one of three Adani executives, besides Gautam and Sagar Adani, indicted for offering bribes to Indian state officials to secure deals, has not responded to a request for comment from Reuters.News of an analyst's price-target hike plus a new round of capital-raising were the sparks that ignited Janux Therapeutics ( JANX 11.65% ) stock on Wednesday. The clinical-stage biotech's share price ended the day nearly 12% higher, and this was on a very good day for the exchange with the S&P 500 rising by 0.6%. Price-target raised, new shares floated Well before market open, Scotiabank pundit George Farmer aggressively raised his price target on Janux, cranking it nearly 50% higher to $62 per share. That doesn't necessarily make him a bull, though, as he maintained his recommendation of sector perform (hold, in other words). According to reports, Farmer wrote that the biotech company's current phase 1 trial of its JANX007 prostate cancer treatment is rather promising so far. That said, the analyst believes Janux hasn't yet honed a sharp competitive edge and isn't yet an attractive enough target for a pharmaceutical company to acquire it. What Janux has done, however, is push to extend its runway with a fresh share issue. After market hours Tuesday, the company said it had launched a $300 million secondary common stock flotation. Certain investors will have the option of purchasing pre-funded warrants instead of shares, and the issue's underwriters are expected to be granted a 30-day option to purchase an additional $45 million worth of shares collectively. A promising future? Janux said it aims to use its proceeds from the share issue "to advance clinical development of its internal product pipeline," in addition to general corporate purposes. The company focuses on cancer treatments, which continues to be a hot area for biotechs, but Farmer makes a good point that Janux hasn't distinguished itself sufficiently. However, it's a relatively young enterprise, and those recent clinical readouts are encouraging.

'Governments across the world are just now recognizing their failure to protect children'How to live stream Vancouver Canucks at Boston Bruins: time, channelsNew York killing: CEO shot dead by masked gunman outside hotel